Literature DB >> 28836530

Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.

Sonika Achalli1, Medhini Madi1, Subhas G Babu1, Shishir Ram Shetty2, Suchetha Kumari3, Supriya Bhat1.   

Abstract

BACKGROUND: Carcinogenesis is a multistep process where a healthy cell has initially a precancerous stage and finally an early cancerous stage. The process of carcinogenesis can be divided into three stages of initiation, promotion, and progression. In this process, there is increased turnover, secretion, and/or shedding from malignant cells. Glycoproteins like sialic acid are expressed on the cell surface. In oral potentially malignant disorders (OPMDs) and oral cancer (OC), the sialic acid level is seen to increase due to high cell turnover and shedding of malignant cells which, in turn, results in the release of glycoproteins like sialic acid into circulation. Glycoproteins also form an important constituent of salivary mucins and hence due to the same mechanism, an increase in sialic acid level is also seen in saliva.
OBJECTIVE: The aim is to estimate serum and salivary sialic acid levels in healthy controls, patients with OPMDs and patients with OC.
MATERIALS AND METHODS: In this observational cross-sectional study, serum and salivary sialic acid levels were estimated in thirty healthy controls, thirty patients with OPMDs and thirty patients with OC.
RESULTS: Serum and salivary sialic acid levels obtained were subjected to statistical analysis. Post hoc Tukey test was used to compare the serum and salivary sialic acid levels of the two study groups to the control group. ANOVA test was used for the comparison of sialic acid levels between the groups. Pearson's correlation coefficient was used to assess correlation (P < 0.05 was considered statistically significant). The mean serum and salivary sialic acid levels were increased significantly in subjects with OPMDs and OC when compared to healthy controls.
CONCLUSION: This study highlights the high expression of sialic acid on outer cell membranes, due to the significant increase in subjects with OPMDs and OC when compared to healthy controls. A significant increase in sialic acid level is also seen in saliva. Hence, it can be stated that saliva can be used as a reliable, noninvasive tool in diagnosis and management of OPMDs and OC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28836530     DOI: 10.4103/ijdr.IJDR_632_16

Source DB:  PubMed          Journal:  Indian J Dent Res        ISSN: 0970-9290


  7 in total

1.  Ratio of Salivary Sialic Acid to Fucose as Tumor Markers in Potentially Malignant Disorders and Oral Cancer.

Authors:  Anandhi Sekar Arthisri; Asokan Sathiyamoorthy; Bhagavatham Meenakshi; Chitraa R Chandran
Journal:  Contemp Clin Dent       Date:  2020-08-07

2.  Is Salivary Sialic Acid a Reliable Biomarker in the Detection of Oral Potentially Malignant Disorder and Oral Squamous Cell Carcinoma.

Authors:  Diana Daniel; Jerin Jose; A Harish Kumar
Journal:  J Maxillofac Oral Surg       Date:  2019-11-20

Review 3.  Sialic acids in gynecological cancer development and progression: Impact on diagnosis and treatment.

Authors:  Anna Y Berghuis; Johan F A Pijnenborg; Thomas J Boltje; Johanna M A Pijnenborg
Journal:  Int J Cancer       Date:  2021-11-17       Impact factor: 7.316

Review 4.  Characterization of Cell Glycocalyx with Mass Spectrometry Methods.

Authors:  Qiongyu Li; Yixuan Xie; Maurice Wong; Carlito B Lebrilla
Journal:  Cells       Date:  2019-08-13       Impact factor: 6.600

5.  Using an Untargeted Metabolomics Approach to Identify Salivary Metabolites in Women with Breast Cancer.

Authors:  Daniele Xavier Assad; Ana Carolina Acevedo; Elisa Cançado Porto Mascarenhas; Ana Gabriela Costa Normando; Valérie Pichon; Helene Chardin; Eliete Neves Silva Guerra; Audrey Combes
Journal:  Metabolites       Date:  2020-12-10

6.  α2-3 Sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and cytokine release and initiates tolerizing T cell programming.

Authors:  Joyce Lübbers; Rui-Jún Eveline Li; Friederike S Gorki; Sven C M Bruijns; Ashley Gallagher; Hakan Kalay; Martino Ambrosini; Douwe Molenaar; Jan Van den Bossche; Sandra J van Vliet; Yvette van Kooyk
Journal:  Immunother Adv       Date:  2021-06-09

Review 7.  Vibrational Spectroscopy Saliva Profiling as Biometric Tool for Disease Diagnostics: A Systematic Literature.

Authors:  Stéphane Derruau; Julien Robinet; Valérie Untereiner; Olivier Piot; Ganesh D Sockalingum; Sandrine Lorimier
Journal:  Molecules       Date:  2020-09-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.